Edgewise Therapeutics Inc (NASDAQ: EWTX) is 223.86% higher on its value in year-to-date trading and has touched a low of $5.12 and a high of $37.29 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The EWTX stock was last observed hovering at around $36.62 in the last trading session, with the day’s loss setting it -1.19%.
Currently trading at $35.43, the stock is 2.94% and 28.43% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.03 million and changing -3.25% at the moment leaves the stock 73.93% off its SMA200. EWTX registered 464.17% gain for a year compared to 6-month gain of 77.15%. The firm has a 50-day simple moving average (SMA 50) of $27.2547 and a 200-day simple moving average (SMA200) of $20.269726.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 16.82% loss in the last 1 month and extending the period to 3 months gives it a 115.38%, and is 5.54% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.52% over the week and 4.89% over the month.
Edgewise Therapeutics Inc (EWTX) has around 88 employees, a market worth around $3.32B and $0.00M in sales. Distance from 52-week low is 591.99% and -4.99% from its 52-week high. The company has generated returns on investments over the last 12 months (-22.52%).
The EPS is expected to grow by 5.89% this year
219.0 institutions hold shares in Edgewise Therapeutics Inc (EWTX), with institutional investors hold 113.60% of the company’s shares. The shares outstanding are 70.45M, and float is at 59.21M with Short Float at 14.33%. Institutions hold 113.07% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 15.02 million shares valued at $270.54 million. The investor’s holdings represent 17.1545 of the EWTX Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 8.91 million shares valued at $160.45 million to account for 10.174 of the shares outstanding. The other top investors are NOVO HOLDINGS A/S which holds 6.34 million shares representing 7.2452 and valued at over $114.26 million, while BLACKROCK INC. holds 6.8698 of the shares totaling 6.02 million with a market value of $108.34 million.
Edgewise Therapeutics Inc (EWTX) Insider Activity
The most recent transaction is an insider sale by Russell Alan J, the company’s Chief Scientific Officer. SEC filings show that Russell Alan J sold 75,000 shares of the company’s common stock on Sep 20 ’24 at a price of $28.27 per share for a total of $2.12 million. Following the sale, the insider now owns 12719.0 shares.
Edgewise Therapeutics Inc disclosed in a document filed with the SEC on Sep 20 ’24 that MOORE JOHN R (General Counsel) sold a total of 50,000 shares of the company’s common stock. The trade occurred on Sep 20 ’24 and was made at $28.37 per share for $1.42 million. Following the transaction, the insider now directly holds 3252.0 shares of the EWTX stock.
Still, SEC filings show that on Sep 23 ’24, MOORE JOHN R (General Counsel) disposed off 20,922 shares at an average price of $27.63 for $0.58 million. The insider now directly holds 3,252 shares of Edgewise Therapeutics Inc (EWTX).
